The study, published in the November 4 issue of the journal Neuron, shows that brain activity controls the balance between stem cells and mature nerve cells and suggests that abnormal brain activity, as it occurs during seizures, may have long-lasting effects on brain development. The results also have implications for replacing brain cells that are damaged or lost through diseases such as Alzheimer’s or Parkinson’s disease.
“One implication is that to get brain cells to form you need a period in which brain activity is low followed by a period of higher activity,” said Scripps Research Professor Hollis Cline, Ph.D., senior author of the study. “Just having high or low brain activity won’t have the same outcome.”
Nerve Cell Development 101
During development, stem cells give rise to nerve cells in the central nervous system. During the first stages of development, stem cells divide, each generating two identical daughter stem cells. This process, called proliferation, serves to increase the pool of stem cells. In later stages, stem cell division generates two different types of cells: a daughter stem cell plus a cell that changes into a mature, functioning nerve cell through a process known as differentiation. And once the nervous system approaches the final stages of development, all divisions give rise to nerve cells, leaving only a few stem cells behind.
So how is the switch from mainly stem cell proliferation to mainly nerve cell differentiation controlled in the developing brain?
It is known that in adult brains, brain activity helps new nerve cells form and existing ones survive. That is why older people are often told to keep their brains active by doing crossword puzzles and other exercises. But no one had looked at the connection between brain activity and nerve cell formation in the developing brain.
Activity is the Switch
To look for a possible link, Cline turned to the frog Xenopus laevis. In tadpoles, stem cells in the visual system—the part of the brain that receives and interprets signals from the eyes—continue to proliferate for several days even as brain circuits are starting to form and become functional. The researchers wanted to ask whether the activity by the newly formed circuits had any effect on stem cell proliferation and nerve cell differentiation. “We chose the visual system because we can control the amount of activity in pretty precise ways,” noted Cline.
First, Cline and her colleague Research Associate Pranav Sharma, Ph.D., determined that the amount of stem cell proliferation in the visual system decreases as the visual circuits are laid out and become active (from about days 7 to 13 in a tadpole’s life). But when the scientists shut off activity in the visual system by keeping some of the tadpoles in darkness for two days, cell proliferation increased and nerve cell differentiation decreased.
These observations suggest that brain activity regulates both stem cell proliferation and nerve cell differentiation, but in opposite ways. As circuits are laid out during development, their activity influences the fate of cells generated through stem cell division, making them stop dividing and mature into nerve cells.
“We have found that a key reason why proliferation slows down during development is that brain activity turns it off,” said Cline.
Identifying a Key Regulator
Cline and Sharma also discovered a protein that may hold the key to how brain activity slows down stem cell proliferation.
During visual system development, as stem cell proliferation decreases, they found that the amount of a protein called Musashi1, which is produced by stem cells, also decreases. On the other hand, the tadpoles kept in the dark for two days, whose visual system was not active, had an increase in both stem cell proliferation and an increase in Musashi1 protein levels in the stem cells.
In a series of experiments, Cline and Sharma either shut down or boosted the production of musashi1 in the tadpoles’ stem cells. They showed that, in the absence of Musashi1, stem cell proliferation slows down. On the other hand, boosting the amounts of Musashi1 increases stem cell proliferation, even in the later stages of development.
“We knew that musashi1 was a marker for stem cells but no one knew that it was controlled by brain activity,” said Cline. The findings suggest that this protein might be used as a way of expanding the stem cell pool in developing brains, and possibly even adult brains.
New Avenues for Therapy
The study by Cline and Sharma shows that proliferation and differentiation are regulated differently by brain activity during development. It is not yet known whether these results apply to the adult brain, which contains a small number of stem cells. If they do, however, one implication is that to promote nerve cell formation, both brain activity and inactivity are necessary.
“You might say do a lot of brain exercises, but if you do not include periods of lower activity you will not have an expanded stem cell pool,” noted Cline. “You have to keep the pool replenished.”
Another question these findings raise is whether abnormal brain activity, as occurs in seizures, has long-lasting effects on developing brains. “Several studies have shown that there are changes in the brain due to seizures but the results are not consistent,” she said. “It’s possible that abnormal brain activity would affect differentiation or proliferation.”
Cline and Sharma plan to pursue these questions in future studies.
Research for the paper, “Visual activity regulates neural progenitor cells in developing Xenopus CNS through Musashi1,” was funded by the National Institutes of Health, Dart Neuroscience LLC, and fellowships from the California Institute of Regenerative Medicine. For more information on the paper, see http://www.cell.com/neuron/abstract/S0896-6273(10)00770-1
About The Scripps Research Institute
The Scripps Research Institute is one of the world’s largest independent, non-profit biomedical research organizations, at the forefront of basic biomedical science that seeks to comprehend the most fundamental processes of life. Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune, cardiovascular, and infectious diseases, and synthetic vaccine development. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, Scripps Research currently employs approximately 3,000 scientists, postdoctoral fellows, scientific and other technicians, doctoral degree graduate students, and administrative and technical support personnel. Headquartered in La Jolla, California, the institute also includes Scripps Florida, whose researchers focus on basic biomedical science, drug discovery, and technology development. Scripps Florida is located in Jupiter, Florida. For more information, see www.scripps.edu
10550 North Torrey Pines Road
La Jolla, California 92037